BiomX Inc. received a written notice from NYSE Regulation stating that it had accepted the Company's compliance plan to regain compliance with NYSE American LLC continued listing standards. The Company submitted a plan on April 24, 2026, and was granted a plan period through September 25, 2027, to regain compliance regarding stockholders' equity requirements. Until compliance is regained, the Company's ticker symbol will include a ".BC" indicator. BiomX Inc. is a biotechnology company that develops therapeutic solutions for infectious diseases.
More from Tessera Defense & Homeland Security Inc.
